Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.

Journal of Virology
Joshua ArringtonJ R Haynes

Abstract

Two plasmid vectors encoding the A and B subunits of cholera toxin (CT) and two additional vectors encoding the A and B subunits of the Escherichia coli heat-labile enterotoxin (LT) were evaluated for their ability to serve as genetic adjuvants for particle-mediated DNA vaccines administered to the epidermis of laboratory animals. Both the CT and the LT vectors strongly augmented Th1 cytokine responses (gamma interferon [IFN-gamma]) to multiple viral antigens when codelivered with DNA vaccines. In addition, Th2 cytokine responses (interleukin 4 [IL-4]) were also augmented by both sets of vectors, with the effects of the LT vectors on IL-4 responses being more antigen dependent. The activities of both sets of vectors on antibody responses were antigen dependent and ranged from no effect to sharp reductions in the immunoglobulin G1 (IgG1)-to-IgG2a ratios. Overall, the LT vectors exhibited stronger adjuvant effects in terms of T-cell responses than did the CT vectors, and this was correlated with the induction of greater levels of cyclic AMP by the LT vectors following vector transfection into cultured cells. The adjuvant effects observed in vivo were due to the biological effects of the encoded proteins and not due to CpG motifs ...Continue Reading

References

Jul 1, 1980·Infection and Immunity·J D ClementsR A Finkelstein
Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·W I LencerJ L Madara
Oct 1, 1996·Nature Medicine·C CondonL D Falo
Jan 1, 1997·Annual Review of Immunology·J J DonnellyM A Liu
Mar 31, 1999·Immunology Today·N A WilliamsT O Nashar
Apr 13, 1999·Infectious Disease Clinics of North America·J R Haynes
Oct 3, 1999·Vaccine·G Del Giudice, R Rappuoli
Aug 15, 2000·European Journal of Immunology·M C GagliardiM T De Magistris
Feb 13, 2001·Cell·A Aderem, D A Hume
Apr 26, 2001·Gene Therapy·A T LarreginaL D Falo

❮ Previous
Next ❯

Citations

Apr 22, 2004·Vaccine·A C M BoonA D M E Osterhaus
Jun 24, 2003·Comparative Immunology, Microbiology and Infectious Diseases·Hansi J DeanJorge E Osorio
Sep 27, 2003·Methods : a Companion to Methods in Enzymology·Nicole A Doria-Rose, Nancy L Haigwood
May 28, 2005·The Lancet Infectious Diseases·Seif S Al-AbriFred J Nye
Apr 22, 2011·Clinical and Vaccine Immunology : CVI·Kenneth C BagleyTimothy R Fouts
Feb 2, 2011·PLoS Neglected Tropical Diseases·Dang Duc AnhJohn D Clemens
May 3, 2014·PLoS Neglected Tropical Diseases·Richelle C CharlesJason B Harris
Jul 23, 2004·Expert Opinion on Biological Therapy·Jeffrey B Ulmer
Aug 19, 2007·Vaccine·Richard J Anderson, Joerg Schneider
Jul 6, 2004·Immunological Reviews·Sylvia van Drunen Littel-van den HurkLorne A Babiuk
Jul 6, 2004·Immunological Reviews·Felix N TokaBarry T Rouse
Sep 10, 2005·Vaccine·Robert J DrapeHansi J Dean
Jun 7, 2005·Advanced Drug Delivery Reviews·Hansi J DeanConnie Schmaljohn
Jun 4, 2004·Expert Opinion on Biological Therapy·Joel R Haynes
Jul 2, 2003·FEMS Immunology and Medical Microbiology·K MittenbühlerM Huber
Apr 14, 2004·Critical Reviews in Clinical Laboratory Sciences·Sharmila ManojSylvia van Drunen Littel-van den Hurk
Jan 4, 2006·The Journal of Gene Medicine·Frank M OrsonPhilip R Wyde
Feb 7, 2007·Expert Review of Vaccines·Suehiro Sakaguchi, Takeshi Arakawa
Apr 6, 2007·Expert Review of Vaccines·Shaw-Wei D TsenT-C Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.